The Aporia · FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes

FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes

Read the original at New York Post ↗

Cite

APA MLA Chicago

Reuters. (2026, September 24). FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes. New York Post. https://nypost.com/2026/09/24/business/fda-approves-eli-lillys-onswik-once-weekly-insulin-injection-for-type-2-diabetes/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Quick Summary

The FDA has approved Eli Lilly's once-weekly insulin injection, Onswik, for patients with type 2 diabetes. This new treatment is designed to be used alongside diet and exercise and could reduce the number of injections by more than 300 per year compared to daily basal insulin. Based on a trial involving over 3,400 participants across four studies, Onswik showed comparable or better reductions in A1C levels than daily basal insulins like glargine. The drug will be available in the United States soon in pre-filled pens with two concentrations and has already received approvals in Europe, Japan, and Mexico.

Written by AI on 2026-09-24, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The US Food and Drug Administration has approved Eli Lilly's once-weekly basal insulin, Onswik, for adults with type 2 diabetes. This new treatment is intended to be used alongside diet and exercise to control high blood sugar levels, offering patients an alternative to daily long-acting insulin injections. Onswik could reduce the number of injections by more than 300 per year compared to once-daily basal insulin treatments. The approval was based on a late-stage trial involving over 3,400 adults with type 2 diabetes across four studies. Onswik is expected to be available in the United States as a pre-filled KwikPen in two concentrations: 500 units per milliliter and 1,000 units per milliliter, in the coming months.

Written for “FDA Approves Insulin Injection” on 2026-10-30, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Signals How these are calculated →

Claims extracted

sentences that state something as happening or true

Uncertain

10%

1 of 10 hedged ("reportedly", "may", "according to")

Leaning

not political

takes no side on a contested political question

Publisher signals

66/100

New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.

Outlets on this story

Health

Same framing elsewhere

articles that frame the event the way this one does

Who wrote this

Reuters

779 article(s) here · 1 carrying a prediction

🔮 Meta had settled with S.J. days before the trial, so Friday’s settlement with K.D.B. means the trial is expected to proceed against Snap only.

2026-10-30 · mixed framing · Meta settles with teen over claims social media caused depression, eating disorders

🔮 “My duty now is not to focus on discussing whether I will remain in office, but on solving the problem, determining exactly what happened and providing clear explanations,” Puente said at a press conference on Friday.

2026-10-30 · mixed framing · Spanish transport minister refuses to resign over second major train crash on his watch

🔮 The global crypto insurance market was valued at $9.37bn in 2025 and is projected to reach $184.98 billion by 2033, according to Data Bridge Market Research.

2026-10-30 · mixed framing · Binance's $6.3bn hack: How crypto insurance works

🔮 No further victims were expected to be found, regional authorities said.

2026-10-30 · assertive framing · Fears Australians caught up in Spanish train disaster that killed 69 people and injured almost 200

🔮 “This was a complex attack, and we are doing all we can in coordination with law enforcement to resolve it,” Binance wrote on X. The firm earlier posted a series of sometimes contradictory messages, insisting that “user funds are completely safe” but also saying it would “cover all losses.

2026-10-30 · assertive framing · Crypto exchange Binance freezes assets after $6.3bn 'complex' security breach

🔮 Now in Year 2 of the revamped format, the league will hold its first-ever Game 7 with a first-time champion awaiting on either side.

2026-10-30 · assertive framing · Sharp-shooting Dream beat Valkyries 80-69 to force Game 7 in WNBA Finals

🔮 Everton will travel to League Two side Fleetwood, who stunned Premier League champions Arsenal on Tuesday.

2026-10-30 · assertive framing · Everton beat Newcastle to set up League Cup quarterfinal with Fleetwood

🔮 Later on Thursday, the Republican National Committee said in a statement that it would also cancel a planned rally in Iowa, home to several competitive congressional races.

2026-10-30 · assertive framing · 'You are disgusting': Trump lashes out at reporter as he cancels weekend rallies ahead of midterm polls

🔮 Binance, the world’s largest cryptocurrency exchange, said a security breach had resulted in an estimated $6.3 billion impact that analysts said could amount to the biggest crypto heist ever and might make investors rethink the risks of owning digital assets.

2026-10-30 · mixed framing · Crypto exchange Binance freezes assets after $6.3 billion security breach

🔮 Two Bailey bridges — bridges built in portable, pre-fabricated sections — may have been washed away, the broadcaster reported.

2026-10-30 · assertive framing · Bhutan glacial flood triggers evacuations along India’s Sankosh River

Wire or desk byline, not an individual reporter.

Also by Reuters

Meta settles with teen over claims social media caused depression, eating disorders

2026-10-30 · New York Post

Russia-Ukraine truce for Oleshky allows aid mission to help starving residents

2026-10-30 · South China Morning Post

Spanish transport minister refuses to resign over second major train crash on his watch

2026-10-30 · Dawn

Binance's $6.3bn hack: How crypto insurance works

2026-10-30 · Dawn

Nothing else under this byline is closely related to this article, so these are simply their most recent.

All 779 articles by Reuters →

Narrative

Claims (10 extracted, 1 hedged)

The US Food and Drug Administration has approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type 2 diabetes, the drugmaker said on Thursday, offering patients an alternative to daily long-acting insulin injections. asserted

drugmaker → approve → injections

Onswik, chemically known as insulin efsitora alfa-gobe, is intended to be used alongside diet and exercise to control high blood sugar. asserted

Onswik → know → sugar

The once-weekly treatment could reduce the number of injections by more than 300 per year compared with once-daily basal insulin, Lilly said. uncertain

Lilly → reduce → insulin

Lilly said Onswik would be available in the United States in the coming months as a pre-filled KwikPen in two concentrations – 500 units per milliliter and 1,000 units per milliliter. asserted

Onswik → say → milliliter

The regulatory approval was based on a late-stage trial, which enrolled more than 3,400 adults with type 2 diabetes across four studies. asserted

which → base → studies

Onswik met the main goal in each study, showing reductions in A1C, a measure of blood sugar, that were not inferior to the daily basal insulins glargine. asserted

that → meet → glargine

Insulin glargine, sold under brands such as Sanofi’s Lantus and Lilly’s Basaglar, is a long-acting, man-made insulin used to control blood sugar in type 1 and type 2 diabetes patients. asserted

glargine → sell → patients

Lilly said Onswik should not be used in patients with type 1 diabetes because of an increased risk of severe hypoglycemia, or dangerously low blood sugar. asserted

Onswik → say → hypoglycemia

Onswik has previously received regulatory approvals in Europe, Japan and Mexico. asserted

Onswik → receive → Europe

In March, US FDA approved Novo Nordisk’s insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 diabetes. asserted

FDA → approve → diabetes

FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes

Quick Summary

AI analysis

Story

Compared with similar articles

Signals How these are calculated →

How this is being covered How these are calculated →

Publisher

Who wrote this

Topics

Subjects

Narrative

Claims (10 extracted, 1 hedged)